United States · FDA National Drug Code directory
Brimonidine tartrate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 82182-321_63e74b48-0ee2-40e8-a81f-008103768e17
- Product NDC
- 82182-321
- Form
- SOLUTION/ DROPS
- Composition / generic term
- brimonidine tartrate
- Labeler
- Pacific Pharma, Inc.
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start / end (source format)
- 20240102
- Source listing expiry
- 20261231
Source-listed ingredients
- BRIMONIDINE TARTRATE — 1 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE, DROPPER in 1 CARTON (82182-321-05) / 5 mL in 1 BOTTLE, DROPPER · 82182-321-05
- 1 BOTTLE, DROPPER in 1 CARTON (82182-321-10) / 10 mL in 1 BOTTLE, DROPPER · 82182-321-10
- 1 BOTTLE, DROPPER in 1 CARTON (82182-321-15) / 15 mL in 1 BOTTLE, DROPPER · 82182-321-15
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →